Skip to main content

Table 1 Baseline characteristics for patients with candida bloodstream infection (BSIs)

From: Antifungal resistance in patients with Candidaemia: a retrospective cohort study

CharacteristicsNumber of Patients (N = 189)
n (%)
Mean Age (years)57.3 ± 17.5
Gender
 Male94 (49.74%)
 Female95 (50.26%)
Bacteremia co-infection79 (41.8%)
Baseline Comorbidities
 Diabetes99 (52.38%)
 Hypertension105 (55.56%)
 Chronic kidney disease24 (12.7%)
 Liver Cirrhosis33 (17.46%)
 Cardiovascular diseases96 (50.79%)
 Lung diseases52 (27.51%)
 Human immunodeficiency virus3 (1.59%)
 Solid organ transplantation8 (4.23%)
 Hematological malignancy9 (4.76%)
 Non hematological malignancy48 (25.4%)
 Neutropenia a25 (13.23%)
 History of IV drug user3 (1.59%)
 Blood/ Platelet transfusion135 (71.43%)
 Recent hospital admission35 (18.52%)
Exposure to medication within 3 months a
 Broad spectrum antibiotics182 (96.3%)
 Polyene antifungal3(1.59%)
 Azole antifungal (Fluconazole)11 (5.82%)
 Echinocandins38 (20.11%)
 Corticosteroids86 (45.5%)
Exposure to medical procedures within 3 months
 TPN20 (10.58%)
 Central line insertion151 (79.89%)
Urine catheter148 (78.31%)
Invasive Ventilation100 (52.91%)
Surgery within 3 months77 (40.74%)
 GI38 (49.35%)
 Non- GI39 (50.65%)
Renal Replacement therapy66 (34.92%)
HD54 (28.57%)
PD4 (2.12%)
CRRT11 (5.82%)
SLID4 (2.12%)
  1. Total parental nutrition (TPN); Gastrointestinal (GI); Hemodialysis (HD); Peritoneal dialysis (PD); Continuous renal replacement therapy (CRRT); Sustained low efficiency dialysis (SLID); Intravenous (IV);aNeutropenia defined as an absolute neutrophil count of, 1.0 109/L or less; N = total number of patients; n = number of patients or events